{"entity":{"type":"insider","cik":"0001971798","url":"/insider/0001971798","json_url":"/insider/0001971798.json","name":"Wambeke David J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2023-04-11","last":"2026-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Wambeke David J.","source":"filing","n_filings":4,"first_seen":"2023-04-11","last_seen":"2026-03-03"}],"transactions":[{"id":5792790,"accession":"0001971798-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001971798-26-000002","line_url":"/filing/0001971798-26-000002#line-1","is_derivative":false,"issuer_cik":"0001500198","issuer_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","issuer_ticker":"NMTC","issuer_name_source":null,"issuer_url":"/issuer/0001500198","owner_cik":"0001971798","owner_name":"Wambeke David J.","owner_display_name":"Wambeke David J.","owner_url":"/insider/0001971798","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":0.6704,"price_display":"0.67","price_state":"stated","total_value":670400.0,"total_display":"670,400.00","total_whole":"670,400","shares_owned_after":1000000.0,"shares_owned_after_display":"1,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-01","filed_date":"2026-03-03","scope":"insider"},{"id":8683327,"accession":"0001235802-23-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-23-000111","line_url":"/filing/0001235802-23-000111#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001971798","owner_name":"Wambeke David J.","owner_display_name":"Wambeke David J.","owner_url":"/insider/0001971798","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.46,"price_display":"2.46","price_state":"stated","total_value":49200.0,"total_display":"49,200.00","total_whole":"49,200","shares_owned_after":527114.0,"shares_owned_after_display":"527,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-16","scope":"insider"},{"id":8199542,"accession":"0001235802-23-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-23-000069","line_url":"/filing/0001235802-23-000069#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001971798","owner_name":"Wambeke David J.","owner_display_name":"Wambeke David J.","owner_url":"/insider/0001971798","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38364.0,"shares_display":"38,364","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":150003.24,"total_display":"150,003.24","total_whole":"150,003","shares_owned_after":507114.0,"shares_owned_after_display":"507,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-26","scope":"insider"},{"id":8303438,"accession":"0001235802-23-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-23-000040","line_url":"/filing/0001235802-23-000040#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001971798","owner_name":"Wambeke David J.","owner_display_name":"Wambeke David J.","owner_url":"/insider/0001971798","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":468750.0,"shares_display":"468,750","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":468750.0,"shares_owned_after_display":"468,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-10","filed_date":"2023-04-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001500198","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","url":"/issuer/0001500198","role":"Officer (Chief Business Officer)","n_filings":1,"first_seen":"2026-03-03","last_seen":"2026-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001401040","name":"DiaMedica Therapeutics Inc.","url":"/issuer/0001401040","role":"Officer (Chief Business Officer)","n_filings":3,"first_seen":"2023-04-11","last_seen":"2023-11-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001971798","retrieved_at":"2026-08-26T04:07:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}